Cargando…

Triglyceride and cardiovascular risk: A critical appraisal

Detalles Bibliográficos
Autores principales:	Singh, Awadhesh Kumar, Singh, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911828/ https://www.ncbi.nlm.nih.gov/pubmed/27366705 http://dx.doi.org/10.4103/2230-8210.183460

Ejemplares similares

Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis
por: Singh, Awadhesh Kumar, et al.
Publicado: (2017)

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

SAVOR-TIMI to DECLARE-TIMI: A Review on Cardiovascular Outcome Trials of Incretin-modulators and Gliflozins
por: Singh, Awadhesh K., et al.
Publicado: (2019)

Triglyceride Level and Cardiovascular Risk Reduction Using Pemafibrate Compared with Fibrates
por: Masuda, Daisaku
Publicado: (2023)

Triglycerides and Cardiovascular Risk
por: Harchaoui, K.E.L, et al.
Publicado: (2009)

Web reports: critically appraising online resources
por: Lapinsky, Stephen, et al.
Publicado: (2002)

Utilization of postnatal care for newborns and its association with neonatal mortality in India: An analytical appraisal
por: Singh, Abhishek, et al.
Publicado: (2012)

Lack of Insight in Psychiatric Illness: A Critical Appraisal
por: Reddy, M. S.
Publicado: (2016)

Efficacy and safety of teneligliptin
por: Singh, Awadhesh Kumar
Publicado: (2017)

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
por: Singh, Awadhesh Kumar, et al.
Publicado: (2015)

Heart Failure Hospitalization with DPP-4 Inhibitors: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Singh, Awadhesh Kumar, et al.
Publicado: (2019)

Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review
por: Singh, Awadhesh Kumar, et al.
Publicado: (2016)

Letter to the editor in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)”
por: Kumar Singh, Awadhesh, et al.
Publicado: (2020)

Sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors combination therapy in type 2 diabetes: A systematic review of current evidence
por: Singh, Awadhesh Kumar, et al.
Publicado: (2016)

Metformin in gestational diabetes: An emerging contender
por: Singh, Awadhesh Kumar, et al.
Publicado: (2015)

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Cerebral Venous Thrombosis: A Critical Appraisal
por: Lal, Amos, et al.
Publicado: (2020)

Smartphone applications for chronic pain management: a critical appraisal
por: Alexander, John C, et al.
Publicado: (2016)

Resilience: A Critical Appraisal of the State of Research for Business and Society
por: Buyl, Tine, et al.
Publicado: (2022)

Hydroxyethyl starch for perioperative fluid management: a critical appraisal
por: Schmidt, André P., et al.
Publicado: (2023)

Does the choice of colloids interfere with the outcome in critically ill patients? A critical appraisal
por: Poelaert, Jan, et al.
Publicado: (2015)

Critical appraisal of an article on factitious schizophrenia
por: Raj, Rajnish, et al.
Publicado: (2006)

Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Skin Stretching for Burn Scar Excision – A Critically Appraised Topic
por: Agha, Riaz A., et al.
Publicado: (2012)

A Critical Appraisal of COVID-19 in Malaysia and Beyond
por: Abdullah, Jafri Malin, et al.
Publicado: (2020)

The Ratio of Triglyceride to High-density Lipoprotein Cholesterol as an Indicator of Risk Stratification for Atherosclerotic Cardiovascular Disease in a Clinical Setting
por: Tani, Shigemasa
Publicado: (2020)

Quality of life and oral potentially malignant disorders: Critical appraisal and prospects
por: Gondivkar, Shailesh M, et al.
Publicado: (2018)

Optimal Cut-off Points of Triglycerides for Cardiovascular Disease Prediction in Japanese Population
por: Hirata, Aya
Publicado: (2023)

Critical appraisal of the role of serum albumin in cardiovascular disease
por: Chien, Shih-Chieh, et al.
Publicado: (2017)

Triglycerides on the Rise!
por: Tada, Hayato, et al.
Publicado: (2021)

Rejoinder in reply to critical appraisal on “factitious schizophrenia”
por: Raj, Rajnish, et al.
Publicado: (2007)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1lls5oh7iqp08j8mhhd3b7isin